Skip to main content

Advertisement

SpringerLink
Log in

Pediatric rheumatology in Turkey

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Pediatric Rheumatology is an emerging specialty in Turkey with increasing number of available centers and specialists all over the country. In this paper, we sought to provide an overview on pediatric rheumatology service in our country, as well as to assess the principle published literature from Turkey in this field. A systematic literature search has been performed to achieve the significance and the impact of this manuscript. The most relevant used databases (PubMed/MEDLINE, Web of Science, SCOPUS) for peer-reviewed studies and reviews in English language published during the last 5 years were screened. In the first part of the manuscript, we tried to give more details on the history of pediatric rheumatology in Turkey. In further text, we put an accent over the most common rheumatologic conditions among children in Turkey, including Familial Mediterranean fever, juvenile idiopathic arthritis, juvenile spondyloarthropathies, and childhood vasculitides. Despite the considerable literature from Turkey on pediatric rheumatic diseases, a need for unique strategies that would guide the management of rheumatic diseases in childhood remains open. The cultural and historical inheritance together with geographical position make the Turkey a suitable ground for investigations in filed of auto-inflammation and all other inflammatory conditions. Prospective, multicentric studies especially among rheumatologic conditions common in this part of the world would give us more relevant data and open new horizons in diseases’ management. International collaborations and databases should be highly encouraged and supported, to make the care of pediatric rheumatic disease uniform.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417

    Article  Google Scholar 

  2. Imamoglu A, Ozen S (1988) Epidemiology of rheumatic heart disease. Arch Dis Child 63:1501–1503

    Article  CAS  Google Scholar 

  3. Ozdogan H, Turunç M, Deringöl B, Yurdakul S, Yazici H (1986) Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial. J Rheumatol 13:124–125

    CAS  PubMed  Google Scholar 

  4. Ozdogan H, Kasapçopur O, Dede H, Arisoy N, Beceren T, Yurdakul S, Yazici H (1991) Juvenile chronic arthritis in a Turkish population. Clin Exp Rheumatol 9:431–435

    CAS  PubMed  Google Scholar 

  5. Ozdogan H, Arisoy N, Kasapçapur O, Sever L, Calişkan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327

    CAS  PubMed  Google Scholar 

  6. Ozdogan H, Ruperto N, Kasapçopur O, Bakkaloglu A, Arisoy N, Ozen S, Ugurlu U, Unsal E, Melikoglu M, Paediatric Rheumatology International Trials Organisation (2001) The Turkish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(4 Suppl 23):S158–S162

    CAS  PubMed  Google Scholar 

  7. Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O (2018) Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 38:67–74

    Article  CAS  Google Scholar 

  8. Barut K, Pamuk G, Adrovic A, Şahin S, Kaplan A, Güler M, Kasapçopur Ö (2018) Comparison of familial Mediterranean fever and juvenile idiopathic arthritis patients according to family origin. Turk Pediatri Ars 53:31–36

    Article  Google Scholar 

  9. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish, FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11

    Article  Google Scholar 

  10. Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, Kasapçopur O, Elhan AH, Doganay B, Ekim M, Kara N, Uncu N, Bakkaloglu A (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395–398

    Article  Google Scholar 

  11. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M (2001) Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9:553–555

    Article  CAS  Google Scholar 

  12. Makay B, Gülez N (2018) Long-term follow-up of paediatric MEFV carriers. Clin Rheumatol 37:1683–1687

    Article  Google Scholar 

  13. Özdel S, Özçakar ZB, Kunt S, Elhan AH, Yalçınkaya F (2016) Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever. Clin Rheumatol 35:1837–1840

    Article  Google Scholar 

  14. Sönmez HE, Esmeray P, Batu ED, Arıcı ZS, Demir S, Sağ E, Özen S, Bilginer Y (2018) Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?. Rheumatol Int 5:1–5 (Epub ahead of print)

    Google Scholar 

  15. Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tağ T (1972) A new approach to the treatment of periodic fever. Med Bull İstanbul 5:44–49

    Google Scholar 

  16. Saatçi U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623

    Article  Google Scholar 

  17. Erden A, Batu ED, Sarı A, Sönmez HE, Armagan B, Demir S, Fırat E, Bilginer Y, Bilgen SA, Karadağ Ö, Kalyoncu U, Kiraz S, Ertenli I, Özen S, Akdogan A (2018) Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol 36(Suppl 115):97–102

    PubMed  Google Scholar 

  18. Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F (2016) Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol 35:441–446

    Article  Google Scholar 

  19. Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M (2018) Canakinumab treatment in children with familial Mediterranean fever: report from a single center. Rheumatol Int 38:879–885

    Article  Google Scholar 

  20. Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S (2015) Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever. Arthritis Res Ther 17:243

    Article  Google Scholar 

  21. Eroglu FK, Beşbaş N, Topaloglu R, Ozen S (2015) Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Rheumatol Int 35:1733–1737

    Article  CAS  Google Scholar 

  22. De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G (2018) Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med 378:1908–1919

    Article  Google Scholar 

  23. Gülez N, Makay B, Sözeri B (2018) Long-term effectiveness and safety of canakinumab in pediatric Familial Mediterranean fever patients. Mod Rheumatol 17:1–13

    Article  Google Scholar 

  24. Nalcacioglu H, Ozkaya O, Genc G, Ayyildiz S, Kefeli M, Elli M, Aydin O, Ceyhan Bilgici M (2018) Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma. Int J Rheum Dis 21:552–559

    Article  CAS  Google Scholar 

  25. Barut K, Adrovic A, Şahin S, Kasapçopur Ö (2017) Juvenile idiopathic arthritis. Balkan Med J 34:90–101

    Article  Google Scholar 

  26. Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25:2445–2449

    CAS  PubMed  Google Scholar 

  27. Cakan M, Aktay-Ayaz N, Keskindemirci G, Ekinci DY, Karadağ ŞG (2017) Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis—265 cases from a Turkish center. Turk J Pediatr 59:548–554

    Article  Google Scholar 

  28. Karacan I, Uğurlu S, Şahin S, Everest E, Kasapçopur Ö, Tolun A, Özdoğan H, Turanli ET (2018) LACC1 gene defects in familial form of juvenile arthritis. J Rheumatol 45:726–728

    Article  CAS  Google Scholar 

  29. Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis(ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W (2017) Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 76:906–913

    Article  CAS  Google Scholar 

  30. Barut K, Yücel G, Sinoplu AB, Şahin S, Adroviç A, Kasapçopur Ö (2015) Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period. Turk Pediatri Ars 50:206–210

    Article  Google Scholar 

  31. Batu ED (2018) Glucocorticoid treatment in juvenile idiopathic arthritis. Rheumatol Int 5:1–15. (Epub ahead of print)

    Google Scholar 

  32. Baris HE, Anderson E, Sozeri B, Dedeoglu F (2018) Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis. Clin Rheumatol 37:3263–3273 (Epub ahead of print)

    Article  Google Scholar 

  33. Sönmez HE, Demir S, Bilginer Y, Özen S (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 6:1–7. (Epub ahead of print)

    Google Scholar 

  34. Tarakci E, Yeldan I, Baydogan SN, Olgar S, Kasapcopur O (2012) Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. J Rehabil Med 44:962–967

    Article  Google Scholar 

  35. Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O (2011) The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol 30:1415–1420

    Article  Google Scholar 

  36. Bayraktar D, Savci S, Altug-Gucenmez O, Manci E, Makay B, Ilcin N, Unsal E (2018) The effects of 8-week water-running program on exercise capacity in children with juvenile idiopathic arthritis: a controlled trial. Rheumatol Int 6:1–7. (Epub ahead of print)

    Google Scholar 

  37. Unal E, Batu ED, Sonmez HE, Arici ZS, Arin G, Karaca NB, Sag E, Demir S, Hakli DA, Ozcadirci A, Oflaz FB, Alpar R, Bilginer Y, Ozen S (2018) A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q. Rheumatol Int 38:1557–1564

    Article  Google Scholar 

  38. Demirkaya E, Ozen S, Sozeri B, Ayaz NA, Kasapcopur O, Unsal E, Makay BB, Barut K, Fidanci BE, Simsek D, Cakan M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) (2018) The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report. JAMAR 38(Suppl 1):395–402

    Google Scholar 

  39. Adrovic A, Barut K, Sahin S, Kasapcopur O (2016) Juvenile Spondyloarthropathies. Curr Rheumatol Rep 18:55

    Article  Google Scholar 

  40. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392

    Google Scholar 

  41. Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M, Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H, Bakkaloglu S, Turker T (2011) The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 29:111–116

    PubMed  Google Scholar 

  42. Adrovic A, Sezen M, Barut K, Sahin S, Acikel C, Demirkaya E, Kasapcopur O (2017) The performance of classification criteria for juvenile spondyloarthropathies. Rheumatol Int 37:2013–2018

    Article  Google Scholar 

  43. Sönmez HE, Batu ED, Demir S, Bilginer Y, Özen S (2017) Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol 108:124–127

    Google Scholar 

  44. Ozer E, Seker D, Taner E, Adrovic A, Sahin S, Barut K, Kasapcopur O (2018) The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever. Clin Exp Rheumatol

  45. Makay B, Gücenmez ÖA, Ünsal E (2016) Inactive disease in enthesitis-related arthritis: association of increased Body Mass Index. J Rheumatol 43:937–943

    Article  Google Scholar 

  46. Barut K, Sahin S, Kasapcopur O (2016) Pediatric vasculitis. Curr Opin Rheumatol 28:29–38

    Article  CAS  Google Scholar 

  47. Batu ED, Sarı A, Erden A, Sönmez HE, Armağan B, Kalyoncu U, Karadağ Ö, Bilginer Y, Akdoğan A, Kiraz S, Özen S (2018) Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey. Scand J Rheumatol 18:1–6

    Google Scholar 

  48. Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O’Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis 69:790–797

    Article  Google Scholar 

  49. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806

    Article  Google Scholar 

  50. Dedeoglu R, Barut K, Oztunc F, Atik S, Adrovic A, Sahin S, Cengiz D, Kasapcopur O (2017) Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up. Cardiol Young 27:1377–1385

    Article  Google Scholar 

  51. Ozen S, Batu ED (2018) Vasculitis Pathogenesis: Can We Talk About Precision Medicine? Front Immunol 9:1892

    Article  Google Scholar 

  52. Garg N, Kasapcopur O, Foster J, Barut K, Tekin A, Kızılkılıç O, Tekin M (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173:827–830

    Article  Google Scholar 

  53. Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931

    Article  Google Scholar 

  54. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920

    Article  CAS  Google Scholar 

  55. Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, Kasapcopur O (2018) Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int 38:129–136

    Article  CAS  Google Scholar 

  56. Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, Özen S (2015) A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol 42:1532–1534

    Article  CAS  Google Scholar 

  57. Kisla Ekinci RM, Balci S, Bisgin A, Hershfield M, Atmis B, Dogruel D, Yilmaz M (2018) Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with Canakinumab. Pediatrics 142:e20180948

    Article  Google Scholar 

  58. Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behçet’s disease: a controlled multicenter study. J Am Acad Dermatol 58:579–584

    Article  Google Scholar 

  59. Behçet H (1937) Über rezidivierende aphtose durch ein virus verursachte geschwü ream mund, am auge und an den genitalien. Derm Wschr 105:115

    Google Scholar 

  60. Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S, Akman-Demir G, Siva A (2011) Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology 77:1900–1905

    Article  CAS  Google Scholar 

  61. Batu ED (2018) Diagnostic/classification criteria in pediatric Behçet’s disease. Rheumatol Int. (Epub ahead of print)

  62. Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S (2017) The performance of different classification criteria in paediatric Behçet’s disease. Clin Exp Rheumatol 108:119–123

    Google Scholar 

  63. Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S, PEDBD group (2016) Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75:958–964

    Article  Google Scholar 

  64. Topcuoglu OM, Topcuoglu ED, Altay CM, Genc S (2017) Imaging pearls of pediatric Behçet’s disease. Eur J Radiol 94:115–124

    Article  Google Scholar 

  65. Sahin S, Adrovic A, Barut K, Canpolat N, Ozluk Y, Kilicaslan I, Caliskan S, Sever L, Kasapcopur O (2018) Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Lupus 27:514–519

    Article  CAS  Google Scholar 

  66. Adrovic A, Sahin S, Barut K, Kasapcopur O (2018) Juvenile scleroderma: a referral center experience. Arch Rheumatol 33(x):i-viii

    Google Scholar 

  67. Barut K, Aydin PO, Adrovic A, Sahin S, Kasapcopur O (2017) Juvenile dermatomyositis: a tertiary center experience. Clin Rheumatol 36:361–366

    Article  Google Scholar 

  68. Artim-Esen B, Şahin S, Çene E, Şahinkaya Y, Barut K, Adrovic A, Özlük Y, Kılıçaslan I, Omma A, Gül A, Öcal L, Kasapçopur Ö, İnanç M (2017) Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 Tertiary centers in Turkey. J Rheumatol 44:619–625

    Article  Google Scholar 

  69. Batu ED, Koşukcu C, Taşkıran E, Sahin S, Akman S, Sözeri B, Ünsal E, Bilginer Y, Kasapcopur O, Alikaşifoğlu M, Ozen S (2018) Whole exome sequencing in early-onset systemic lupus erythematosus. J Rheumatol. (Epub ahead of print)

  70. Foeldvari I, Klotsche J, Torok SK, Kasapcopur O, Adrovic A, Stanevicha V, Terreri MT, Alexeeva E, Katsicas M, Cimaz M, KostikM, Lehman T, Sifuentes-Giraldo WA, Smith V, Sztajnbok F, Avcin T, Santos MJ, Moll M, Nemcova D, Battagliotti C, Eleftheriou D, Janarthanan M, Kallinich T, Anton J, Minden K, Nielsen S, Uziel Y, Helmus N (2018) Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroder and Relat Disord. (Epub ahead of print)

Download references

Funding

No funding was received for this study.

Author information

Authors and Affiliations

  1. Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey

    Amra Adrovic & Ozgur Kasapcopur

Authors
  1. Amra Adrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozgur Kasapcopur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozgur Kasapcopur.

Ethics declarations

Conflict of interest

None of the authors of this paper has a conflict of interest, including specific financial interests, relationships and/or affiliations relevant to the subject matter or materials included.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adrovic, A., Kasapcopur, O. Pediatric rheumatology in Turkey. Rheumatol Int 39, 431–440 (2019). https://doi.org/10.1007/s00296-018-04236-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-018-04236-x

Keywords

Search

Navigation